Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one […]
Trius Therapeutics is a great local company which recently had an initial public offering (IPO), quite a feat in this economy. What is the secret to their success? They focus on antibacterials for life threatening […]
We’re going to try something new for the San Diego Biotechnology Network in September. The folks at Halozyme have offered to start hosting events quarterly at their site in Sorrento Valley, and we’ll kick of […]
June 2010 marks the 10th anniversary of the sequencing of the human genome. As Francis Collins has pointed out, “we invariably overestimate the short-term impacts of new technologies and underestimate their longer-term effects.” As a […]
The California Institute for Regenerative Medicine (CIRM) granted a local interdisciplinary research team from UCSD, Salk, and Life Technologies $11.5 million for research aimed at finding a cure for amyotrophic lateral sclerosis (ALS), or Lou […]
At the afternoon session of the Society for Biomolecular Science in Phoenix, it’s all about epigenetics, the study of heritable changes that don’t involve changes in genetic sequence. Epigenetics explains why identical twins turn out a little different and why even cloned cows will have different coloration patterns.
I went to a morning session on stem cells on day 2 of the Society for Biomolecular Science meeting in Phoenix, a meeting focused on advancements in drug discovery and screening technology.? After this, it’s […]
I’m blogging from the Society for Biomolecular Sciences conference in Phoenix, the organizers were kind enough to offer two of us complimentary passes. I was surprised that the sessions were separated into disease area, technique, […]